EB
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV) : a multicenter, international, non-randomized clinical trial study protocol | BMC infectious diseases | 2024 | 15 | 5 | |||
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long‐Acting Intramuscular Injection in Real‐World People with HIV | Clinical pharmacology and therapeutics | 2024 | 4 | 1 | |||
Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3) | The journal of infectious diseases | 2024 | 27 | 2 | |||
Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy | Clinical infectious diseases | 2023 | 43 | 13 | |||
Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV) : A Study Combining Modelling and Swiss HIV Cohort Data | Clinical infectious diseases | 2023 | 61 | 11 | |||
Viral suppression and retention in HIV care during the postpartum period among women living with HIV : a longitudinal multicenter cohort study | The Lancet regional health. Europe | 2023 | 13 | 2 | |||
Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor‐containing regimen | British journal of clinical pharmacology | 2023 | 57 | 12 | |||
External validation of the Dat'AIDS score : A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older | HIV medicine | 2023 | 54 | 7 | |||
Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV Coinfection | Clinical infectious diseases | 2023 | 76 | 0 | |||
Incidence of sexually transmitted infections and association with behavioural factors: Time-to-event analysis of a large pre-exposure prophylaxis (PrEP) cohort | HIV medicine | 2023 | 51 | 13 | |||
Comparison of five different risk scores to predict incident type 2 diabetes in the Swiss HIV cohort study | AIDS | 2023 | 62 | 8 | |||
Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV : The Swiss HIV Cohort Study | The Journal of infectious diseases | 2023 | 43 | 10 | |||
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2) | Open forum infectious diseases | 2023 | 13 | 5 | |||
Understanding the Decline of Incident, Active Tuberculosis in People With Human Immunodeficiency Virus (HIV) in Switzerland | Clinical infectious diseases | 2023 | 45 | 7 | |||
Triggers of change in sexual behavior among people with HIV: The Swiss U = U statement and Covid-19 compared | The journal of infectious diseases | 2023 | 49 | 20 | |||
Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort Study | Clinical infectious diseases | 2023 | 54 | 12 | |||
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2) | Open forum infectious diseases | 2023 | 10 | 7 | |||
Sexual Behaviour and STI Incidence in Sexually Active MSM Living With HIV in Times of COVID-19 | Open forum infectious diseases | 2023 | 51 | 9 | |||
Legionnaires' disease in Switzerland: rationale and study protocol of a prospective national case-control and molecular source attribution study (SwissLEGIO) | Infection | 2023 | 35 | 8 | |||
A Phylogeny-aware GWAS Framework to Correct for Heritable Pathogen Effects on Infectious Disease Traits | Molecular biology and evolution | 2022 | 102 | 42 | |||
Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 Epidemics | Journal of acquired immune deficiency syndromes | 2022 | 111 | 20 | |||
An Approach to Quantifying the Interaction between Behavioral and Transmission Clusters | Viruses | 2022 | 48 | 6 | |||
LOw-dose CT Or Lung UltraSonography versus standard of care based-strategies for the diagnosis of pneumonia in the elderly: protocol for a multicentre randomised controlled trial (OCTOPLUS) | BMJ open | 2022 | 90 | 55 | |||
Female Genital Mutilation/Cutting in the Swiss HIV Cohort Study: A Cross-Sectional Study | Journal of immigrant and minority health | 2022 | 43 | 21 | |||
Transfer of antiretroviral drugs into breastmilk : a prospective study from the Swiss Mother and Child HIV Cohort Study | Journal of antimicrobial chemotherapy | 2022 | 38 | 10 | |||
A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort Study | The journal of infectious diseases | 2022 | 56 | 0 | |||
Impact of interactive computerised decision support for hospital antibiotic use (COMPASS): an open-label, cluster-randomised trial in three Swiss hospitals | Lancet. Infectious diseases | 2022 | 141 | 172 | |||
Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study | The journal of antimicrobial chemotherapy | 2022 | 50 | 0 | |||
Anticholinergic and sedative medications are associated with neurocognitive performance of well treated people with human immunodeficiency virus | Open forum infectious diseases | 2022 | 28 | 11 | |||
A highly virulent variant of HIV-1 circulating in the Netherlands | Science | 2022 | 124 | 15 | |||
Risk Factors and Incidence of Sexually Transmitted Infections in the Swiss HIV Cohort Study | Open forum infectious diseases | 2022 | 77 | 33 | |||
Decrease of condom use in heterosexual couples and its impact on pregnancy rates: the Swiss HIV Cohort Study (SHCS) | HIV medicine | 2022 | 57 | 9 | |||
Using longitudinally sampled viral nucleotide sequences to characterize the drivers of HIV-1 transmission | HIV Medicine | 2021 | 187 | 0 | |||
Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study | Open Forum Infectious Diseases | 2021 | 211 | 85 | |||
Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link | eLife | 2021 | 118 | 44 | |||
The role of Human Immunodeficiency Virus (HIV) asymptomatic status when starting antiretroviral therapy on adherence and treatment outcomes and implications for test and treat: the swiss HIV Cohort Study | Clinical Infectious Diseases | 2021 | 115 | 0 | |||
Identifying and characterizing trans women in the swiss HIV Cohort Study as an epidemiologically distinct risk group | Clinical Infectious Diseases | 2021 | 121 | 0 | |||
Increasing Frequency and Transmission of HIV-1 Non-B Subtypes among Men Who Have Sex with Men in the Swiss HIV Cohort Study | The Journal of Infectious Diseases | 2021 | 112 | 0 | |||
Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial | EClinicalMedicine | 2021 | 561 | 95 | |||
Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV : A Cohort Study | Annals of internal medicine | 2021 | 125 | 0 | |||
Differences in social and mental well-being of long-term survivors among people who inject drugs and other participants in the Swiss HIV Cohort Study : 1980-2018 | Antiviral therapy | 2020 | 26 | 0 | |||
HCV genetic diversity can be used to infer infection recency and time since infection | Viruses | 2020 | 151 | 51 | |||
Host genomics of the HIV-1 reservoir size and its decay rate during suppressive antiretroviral treatment | Journal of Acquired Immune Deficiency Syndromes | 2020 | 175 | 0 | |||
Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV | PLoS biology | 2020 | 47 | 8 | |||
Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial | PLOS Medicine | 2020 | 140 | 88 | |||
Repeated syphilis episodes in HIV-infected men who have sex with men: a multicenter prospective cohort study on risk factors and the potential role of syphilis immunity | Open Forum Infectious Diseases | 2020 | 237 | 86 | |||
Phylogenetic cluster analysis identifies virological and behavioral drivers of HIV transmission in MSM | Clinical Infectious Diseases | 2020 | 331 | 12 | |||
How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population? | HIV medicine | 2020 | 56 | 9 | |||
Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART | Nature Communications | 2020 | 176 | 37 | |||
Contribution of Genetic Background and Data Collection on Adverse Events of Anti–human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular Filtration Rate | Clinical Infectious Diseases | 2020 | 223 | 0 | |||
Emergence of drug resistance in the Swiss HIV Cohort Study under potent antiretroviral therapy is observed in socially disadvantaged patients | Clinical Infectious Diseases | 2020 | 273 | 3 | |||
Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART | Nature Communications | 2019 | 246 | 93 | |||
Impact of the M184V/I Mutation on the efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV treatment-experienced patients | Open Forum Infectious Diseases | 2019 | 249 | 190 | |||
HIV Transmission Chains Exhibit Greater HLA-B Homogeneity Than Randomly Expected | Journal of Acquired Immune Deficiency Syndromes | 2019 | 236 | 0 | |||
Emtricitabine and lamivudine concentrations in saliva: a simple suitable test for treatment adherence | The journal of antimicrobial chemotherapy | 2019 | 43 | 0 | |||
Changing trends in international versus domestic HCV transmission in HIV-positive MSM: A perspective for the DAA scale-up era | The Journal of Infectious Diseases | 2019 | 736 | 202 | |||
Antibodies against HPV16E6 oncoprotein in the Swiss HIV cohort study: Kinetics and anal cancer risk prediction | International Journal of Cancer | 2019 | 255 | 110 | |||
A systematic phylogenetic approach to study the interaction of HIV-1 with coinfections, noncommunicable diseases, and opportunistic diseases | The Journal of Infectious Diseases | 2019 | 262 | 0 | |||
Why do sub‐Saharan Africans present late for HIV care in Switzerland ? | HIV medicine | 2019 | 40 | 0 | |||
Viral diversity based on next-generation sequencing of HIV-1 provides precise estimates of infection recency and time since infection | The Journal of Infectious Diseases | 2019 | 221 | 0 | |||
On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling study | Journal of viral hepatitis | 2018 | 1 650 | 420 | |||
Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study | Liver International | 2018 | 413 | 0 | |||
Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study | Virus Evolution | 2018 | 283 | 64 | |||
Lipodystrophy Increases the Risk of CKD Development in HIV-Positive Patients in Switzerland: The LIPOKID Study | Kidney International Reports | 2018 | 401 | 141 | |||
The cumulative impact of harm reduction on the swiss HIV epidemic: cohort study, mathematical model, and phylogenetic analysis | Open Forum Infectious Diseases | 2018 | 268 | 76 | |||
Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T-Cell Decline, and Per-Parasite Pathogenicity | Molecular Biology and Evolution | 2018 | 430 | 159 | |||
Is breastfeeding an equipoise option in effectively treated HIV-infected mothers in a high-income setting? | Swiss Medical Weekly | 2018 | 374 | 0 | |||
Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model-based analysis in Switzerland | HIV Medicine | 2018 | 495 | 0 | |||
Study protocol for a multicentre, cluster randomised, superiority trial evaluating the impact of computerised decision support, audit and feedback on antibiotic use: the COMPuterized Antibiotic Stewardship Study (COMPASS) | BMJ Open | 2018 | 506 | 217 | |||
Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity | The Journal of experimental medicine | 2018 | 259 | 91 | |||
Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals | Medicine (Philadelphia) | 2017 | 352 | 154 | |||
Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population | AIDS | 2017 | 356 | 145 | |||
Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis | eLife | 2017 | 438 | 162 | |||
Hepatitis delta-associated mortality in HIV/HBV-coinfected patients | Journal of Hepatology | 2017 | 347 | 294 | |||
Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study | HIV Medicine | 2017 | 336 | 0 | |||
High prevalence of physical inactivity among patients from the Swiss HIV Cohort Study | AIDS Care | 2017 | 336 | 310 | |||
Human papillomavirus antibody response following HAART initiation among MSM | AIDS | 2017 | 371 | 0 | |||
Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study | Clinical Infectious Diseases | 2017 | 329 | 0 | |||
Adverse events of raltegravir and dolutegravir | AIDS | 2017 | 363 | 140 | |||
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study | BMC Infectious Diseases | 2017 | 367 | 154 | |||
Mining for pairs: shared clinic visit dates identify steady HIV-positive partnerships | HIV Medicine | 2017 | 388 | 0 | |||
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial | The Lancet Infectious Diseases | 2017 | 506 | 0 | |||
Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared | International journal of infectious diseases | 2016 | 451 | 129 | |||
Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions | Hepatology | 2016 | 641 | 214 | |||
Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland | Scientific Reports | 2016 | 1 015 | 250 | |||
Contribution of Genetic Background and Clinical Risk Factors to Low-Trauma Fractures in Human Immunodeficiency Virus (HIV)-Positive Persons: The Swiss HIV Cohort Study | Open Forum Infectious Diseases | 2016 | 428 | 230 | |||
Determinants of HIV-1 broadly neutralizing antibody induction | Nature Medicine | 2016 | 484 | 384 | |||
Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study | The Journal of Infectious Diseases | 2016 | 371 | 186 | |||
Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study | International journal of cancer | 2016 | 583 | 225 | |||
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis | Clinical Infectious Diseases | 2016 | 613 | 1 | |||
HIV-1 Transmission During Recent Infection and During Treatment Interruptions as Major Drivers of New Infections in the Swiss HIV Cohort Study | Clinical Infectious Diseases | 2016 | 449 | 140 | |||
Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational period | HIV medicine | 2016 | 437 | 0 | |||
Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland | AIDS | 2015 | 46 | 0 | |||
Reasons for late presentation to HIV care in Switzerland | Journal of the International AIDS Society | 2015 | 38 | 3 | |||
Syphilis: Diagnostik und Behandlung | Swiss Medical Forum | 2015 | 285 | 467 | |||
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012 | The Journal of infectious diseases | 2015 | 534 | 0 | |||
Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population | Open forum infectious diseases | 2015 | 519 | 214 | |||
Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disorders | AIDS research and therapy | 2015 | 559 | 283 | |||
Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study | Journal of Antimicrobial Chemotherapy | 2015 | 393 | 154 | |||
Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV | International journal of epidemiology | 2014 | 665 | 409 | |||
Disentangling human tolerance and resistance against HIV | PLoS biology | 2014 | 577 | 309 | |||
The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients | AIDS | 2014 | 468 | 0 | |||
AIDS defining opportunistic infections in patients with high CD4 counts in the combination antiretroviral therapy (cART) era: things ain't what they used to be | Journal of the International AIDS Society | 2014 | 554 | 239 | |||
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients | AIDS | 2014 | 516 | 0 | |||
Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study | Clinical infectious diseases | 2014 | 641 | 0 | |||
Social Meets Molecular: Combining Phylogenetic and Latent Class Analyses to Understand HIV-1 Transmission in Switzerland | American journal of epidemiology | 2014 | 779 | 24 | |||
Higher risk of incident hepatitis C virus coinfection among men who have sex with men, in whom the HIV genetic bottleneck at transmission was wide | The Journal of infectious diseases | 2014 | 521 | 0 | |||
Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study | Open forum infectious diseases | 2014 | 913 | 328 | |||
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection | The Journal of infectious diseases | 2013 | 588 | 0 | |||
High proportion of healthcare-associated urinary tract infection in the absence of prior exposure to urinary catheter: a cross-sectional study | Antimicrobial resistance and infection control | 2013 | 630 | 1 413 | |||
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study | HIV medicine | 2013 | 567 | 0 | |||
The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients | PLoS computational biology | 2013 | 619 | 222 | |||
HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis | PLOS genetics | 2013 | 856 | 596 | |||
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals | Pharmacogenetics and genomics | 2013 | 553 | 0 | |||
Adherence as a Predictor of the Development of Class-Specific Resistance Mutations: The Swiss HIV Cohort Study | PloS one | 2013 | 539 | 539 | |||
Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS) | Journal of acquired immune deficiency syndromes | 2013 | 529 | 0 | |||
A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control | eLife | 2013 | 586 | 222 | |||
Association of Alcohol Consumption and HIV Surrogate Markers in Participants of the Swiss HIV Cohort Study | Journal of acquired immune deficiency syndromes | 2013 | 505 | 0 | |||
The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study | Antiviral therapy | 2013 | 680 | 0 | |||
Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study | The Journal of infectious diseases | 2013 | 584 | 0 | |||
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection | British journal of cancer | 2012 | 504 | 1 041 | |||
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir | AIDS | 2012 | 567 | 0 | |||
Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens | PloS one | 2012 | 579 | 250 | |||
Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians | HIV medicine | 2012 | 538 | 0 | |||
Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic | Clinical infectious diseases | 2012 | 500 | 0 | |||
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations | Clinical infectious diseases | 2012 | 994 | 238 | |||
Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study | Journal of acquired immune deficiency syndromes | 2012 | 562 | 0 | |||
Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study | HIV medicine | 2012 | 542 | 1 | |||
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients | PloS one | 2012 | 583 | 214 | |||
Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes | PloS one | 2012 | 557 | 438 | |||
Improved Virological Outcome in White Patients Infected With HIV-1 Non-B Subtypes Compared to Subtype B | Clinical infectious diseases | 2011 | 538 | 368 | |||
Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection | Clinical infectious diseases | 2011 | 830 | 720 | |||
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study | HIV medicine | 2011 | 558 | 0 | |||
Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients : The ACHIEV2E Collaboration Study Group | Clinical infectious diseases | 2011 | 52 | 0 | |||
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals: the Swiss HIV Cohort Study | Journal of translational medicine | 2011 | 610 | 279 | |||
Overall burden of healthcare-associated infections among surgical patients. Results of a national study | Annals of surgery | 2011 | 536 | 0 | |||
The Role of Migration and Domestic Transmission in the Spread of HIV-1 Non-B Subtypes in Switzerland | The Journal of infectious diseases | 2011 | 613 | 583 |